Nephros (NEPH) Raw Materials (2017 - 2026)
Nephros' quarterly Raw Materials came in at $354000.0 in Q1 2026, up 7.93% year-on-year from $328000.0 in Q1 2025, and up 36.68% quarter-over-quarter from $259000.0 in Q4 2025.
Nephros has reported Raw Materials for 10 years, with the latest figure at $354000.0 in Q1 2026.
- For the quarter ending Q1 2026, Raw Materials rose 7.93% year-over-year to $354000.0; the trailing twelve-month figure through Mar 2026 stood at $354000.0 (up 7.93% YoY), and the FY2025 full-year result was $259000.0, down 26.84% from the prior year.
- Raw Materials for Q1 2026 stood at $354000.0, up from $259000.0 in the prior quarter.
- The five-year high for Raw Materials was $1.1 million in Q1 2022, with the low at $209000.0 in Q3 2025.
- Average Raw Materials over 5 years is $441823.5, with a median of $373000.0 recorded in 2023.
- Year-over-year, Raw Materials rose 15.14% in 2022 and sank 57.71% in 2023.
- Tracing NEPH's Raw Materials over 5 years: stood at $422000.0 in 2022, then declined by 22.75% to $326000.0 in 2023, then grew by 8.59% to $354000.0 in 2024, then decreased by 26.84% to $259000.0 in 2025, then surged by 36.68% to $354000.0 in 2026.
- The last three Raw Materials figures came in at $354000.0 (Q1 2026), $259000.0 (Q4 2025), and $209000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 354,000.00 |
| Dec 31, 2025 | 259,000.00 |
| Sep 30, 2025 | 209,000.00 |
| Jun 30, 2025 | 258,000.00 |
| Mar 31, 2025 | 328,000.00 |
| Dec 31, 2024 | 354,000.00 |
| Sep 30, 2024 | 369,000.00 |
| Jun 30, 2024 | 390,000.00 |
| Mar 31, 2024 | 389,000.00 |
| Dec 31, 2023 | 326,000.00 |
| Sep 30, 2023 | 373,000.00 |
| Jun 30, 2023 | 452,000.00 |
| Mar 31, 2023 | 447,000.00 |
| Dec 31, 2022 | 422,000.00 |
| Sep 30, 2022 | 499,000.00 |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 1.06 Mn |
| Dec 31, 2021 | 807,000.00 |
| Sep 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 920,000.00 |
| Mar 31, 2021 | 918,000.00 |
| Dec 31, 2020 | 964,000.00 |
| Sep 30, 2020 | 781,000.00 |
| Jun 30, 2020 | 606,000.00 |
| Mar 31, 2020 | 365,000.00 |
| Dec 31, 2019 | 359,000.00 |
| Sep 30, 2019 | 354,000.00 |
| Jun 30, 2019 | 282,000.00 |
| Mar 31, 2019 | 273,000.00 |
| Dec 31, 2018 | 280,000.00 |
| Sep 30, 2018 | 93,000.00 |
| Jun 30, 2018 | 74,000.00 |
| Mar 31, 2018 | 73,000.00 |
| Dec 31, 2017 | 51,000.00 |
| Sep 30, 2017 | 53,000.00 |